Shell Asset Management CO Acadia Pharmaceuticals Inc Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Shell Asset Management CO holds 6,530 shares of ACAD stock, worth $111,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,530

Previous 6,904 5.42%

Holding current value

$111,467

Previous $112,000 10.71%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$15.14 - $19.14 $5,662 - $7,158	-374 Reduced 5.42%	6,530 $100,000
Q1 2024 Jul 31, 2024	SELL	$17.79 - $30.86 $7,738 - $13,424	-435 Reduced 5.93%	6,904 $112,000
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $51,751 - $89,771	2,909 Added 65.67%	7,339 $136,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $28,073 - $42,921	-1,351 Reduced 23.37%	4,430 $139,000
Q3 2023 Nov 08, 2023	SELL	$20.84 - $33.47 $1,833 - $2,945	-88 Reduced 1.5%	5,781 $120,000
Q2 2023 Jul 28, 2023	SELL	$17.8 - $25.65 $569 - $820	-32 Reduced 0.54%	5,869 $141,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $326 - $418	-20 Reduced 0.34%	5,901 $111,000
Q4 2022 Feb 07, 2023	SELL	$14.2 - $18.63 $16,358 - $21,461	-1,152 Reduced 16.29%	5,921 $94,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $26,611 - $34,457	-1,886 Reduced 21.05%	7,073 $116,000
Q2 2022 Aug 09, 2022	BUY	$13.01 - $27.22 $60,275 - $126,110	4,633 Added 107.1%	8,959 $126,000
Q1 2022 May 04, 2022	SELL	$20.94 - $27.5 $13,673 - $17,957	-653 Reduced 13.12%	4,326 $105,000
Q4 2021 Feb 09, 2022	SELL	$16.79 - $27.09 $1,376 - $2,221	-82 Reduced 1.62%	4,979 $116,000
Q3 2021 Nov 04, 2021	SELL	$15.78 - $24.77 $3,156 - $4,954	-200 Reduced 3.8%	5,061 $84,000
Q1 2021 May 10, 2021	SELL	$25.02 - $54.99 $133,156 - $292,656	-5,322 Reduced 50.29%	5,261 $136,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $106,334 - $147,142	-2,591 Reduced 19.67%	10,583 $566,000
Q2 2020 Aug 10, 2020	SELL	$39.26 - $52.73 $5,810 - $7,804	-148 Reduced 1.11%	13,174 $639,000
Q1 2020 May 11, 2020	SELL	$31.65 - $46.87 $6,424 - $9,514	-203 Reduced 1.5%	13,322 $563,000
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $10,718 - $15,214	-296 Reduced 2.14%	13,525 $579,000
Q3 2019 Nov 12, 2019	SELL	$22.22 - $44.01 $2,644 - $5,237	-119 Reduced 0.85%	13,821 $497,000
Q2 2019 Aug 12, 2019	SELL	$23.32 - $28.12 $7,439 - $8,970	-319 Reduced 2.24%	13,940 $373,000
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $17,184 - $27,504	-1,200 Reduced 7.76%	14,259 $231,000
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $13,156 - $19,502	-873 Reduced 5.35%	15,459 $236,000
Q4 2017 Feb 09, 2018	BUY	$26.84 - $39.14 $438,350 - $639,234	16,332 New	16,332 $492,000
Q3 2017 Oct 18, 2017	SELL	$29.49 - $38.37 $342,732 - $445,936	-11,622 Closed	0 $0
Q1 2017 Oct 20, 2017	SELL	N/A	-4,988 Reduced 30.03%	11,622 $400,000
Q4 2016 Oct 20, 2017	SELL	N/A	-17,034 Reduced 50.63%	16,610 $479,000
Q3 2016 Oct 20, 2017	BUY	N/A	33,644	33,644 $1.07 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Acadia Pharmaceuticals Inc Transaction History